| ||
| ||
| ||
| Roche's Confidence Needs Checks Wall Street Journal (blog) 2011 will be the test, as Roche' plans to file three experimental cancer drugs, RG7204, RG3616 and pertuzumab. Given recent last-minute failures when drugs ... See all stories on this topic » | ||
| ||
| ||
| Allergan 4Q Profit Up 19%; EPS Outlooks Below Street Wall Street Journal While the Food and Drug Administration recently said it is investigating a possible link between breast implants and a rare type of cancer, ... See all stories on this topic » | ||
| Human test review group's work is changing The Keene Sentinel African-American women are being studied to see what breast cancer treatments work best. Asian-Americans are being surveyed on the causes of problem ... See all stories on this topic » | ||
| Viral Genetics Issues 2010 Year in Review, 2011 Outlook PR Newswire (press release) The compounds being studied in these trials are combinations of drugs or other compounds that, individually, are already approved by the FDA for non-cancer ... See all stories on this topic » | ||
| Roche improves profits but misses expectations CITY A.M. Roche downgraded its forecast sales revenue from its breast cancer drug Avastin to SwFr7bn from SwFr8bn and said it expected low single-digit sales growth ... See all stories on this topic » | ||
| LA's richest man buys Cambridge start-up that sells intelligent pill packaging Boston Globe Soon-Shiong earned his fortune in the pharmaceutical industry (he helped develop a breast cancer drug called Abraxane), and he's apparently interested in ... See all stories on this topic » | ||
| Officials Consider Requiring Insurers to Offer Free Contraceptives New York Times In recent years, many health plans have increased co-payments for prescription drugs, so even women with insurance may end up paying half the cost of ... See all stories on this topic » | ||
| Roche Reduces Avastin Forecast as Revenue Declines San Francisco Chronicle Roche won US approval of Avastin for breast cancer in 2008 under an accelerated review that required the company to conduct trials proving the drug slows ... See all stories on this topic » | ||
| Roche Curbs Avastin Outlook On FDA Decision, Strong Franc Wall Street Journal The reduction was partly due to a recent decision by the US Food and Drug Administration to block Avastin as a treatment for breast cancer, as well as the ... See all stories on this topic » | ||
| BioSante Pharmaceuticals, Inc. To Provide Update on LibiGel® Safety Study at ... Business Wire (press release) BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II ... See all stories on this topic » | ||
| European Market Update: Bailout prospects narrows peripheral spreads in session Fxtraders.eu ... challenge for Roche is FDA's ruling that Avastin, company's leading drug, should not be used in Docetaxel for treatment of HER2-negative breast cancer. ... See all stories on this topic » |
| ||
| QNST, PWRM, ALME – Afternoon Stock Highlights! from PennyToBuck ... By admin This platform has specific application in the area of drug resistance to chemotherapeutic agents in cancer. By the time development of resistance to chemotherapeutic agents is detected, it is usually too late to save the patient. ... BC-SeraPro is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing ... Stock Market Newsletters - http://thestockmarketwatch.com/newsletters/ | ||
| Cancer Drug Avastin Linked To Fatal Side Effects ... By admin The Food and Drug Administration has actually approved the drug to be used on patients suffering from lung, kidney, brain, and breast cancers, but the F.D.A. has recently revoked its approval for breast cancer. ... SmartAboutHealth.Net - http://smartabouthealth.net/ | ||
| Identification of Candidate Small-Molecule Therapeutics to Cancer ... By PLoS ONE For cervical cancer, our results suggested that potential drugs are likely to involve the EGFR pathway; and with the breast cancer dataset, we identified candidates that are involved in prostaglandin inhibition. Thus the gene- signature ... Elites TV - http://elitestv.com/ | ||
| hair loss after surgery – Gastric Bypass Causes Hair Loss: Can It ... By admin A popular anti-cancer drug called Tamoxifen is known for causing hair loss as a side effect. Tamoxifen is a drug used in treating breast cancer. It is an important chemotherapy or anti-cancer medication that kills the cancer cells. ... Reasons For Hair Loss - http://www.hairloss-remedies.com/ | ||
| Estrogen linked with lower dementia risk when taken in middle age ... By admin Stockpiling antiviral drugs as a weapon against pandemic flu saves lives but, when measured as a tool for averting economic damage, is an option only open to rich countries, a study published on Wednesday said. ... A hip fracture is not common in a 54-year-old woman, unless she is a 54-year-old breast cancer survivor, according to a new Northwestern Medicine study. Researchers found that a combination of early menopause due to breast cancer treatment and common drugs used ... Biology and Medicine - http://enterprisepost.com/biomed/ | ||
| TOPS, PWRM, HPOL, NOOF - CRWEWallstreet.com Stock Report! February ... By The Editor The protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer, neurodegenerative disease and drug resistance in cancer. The Company is in a strong ... CRWE Wallstreet - http://crwewallstreet.com/ | ||
| Healthcare Sales & Marketing Network: Lilly, Bristol-Myers Squibb ... By Eli Lilly ALIMTA is approved by the FDA in combination with cisplatin (another chemotherapy drug) for the initial treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. .... GEMZAR is approved by the FDA in combination with paclitaxel for the first-line treatment of patients with metastatic breast cancer after they have received another type of chemotherapy called an anthracycline, unless their medical condition did not allow them to receive ... HSMN NewsFeed - http://salesandmarketingnetwork.com/?q=Save+Us+From+Berlusconi | ||
| ATV, CSV, HIO, PWRM - Stock Reports! from DoubleInStocks.com ... By admin _____ Power3 Medical Products, Inc. (PWRM.OB) Drug Resistance to Chemotherapeutic Agents in Cancer Power3's technology has the potential to be used to. ... Power3's products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, ... Double In Stocks - http://doubleinstocks.com/ |
| ||
| Breast Cancer Drug Shows Promise in Treating Lung Cancer - KFSM A drug that is widely used to treat breast cancer , may also help extend the lives of those who suffer from lung cancer . www.5newsonline.com/.../kfsm-health-breast-cancer-drug,0,4... | ||
| Cancer Drug Avastin Linked to Death Risk - on RxList And in December 2010, the agency moved to rescind the drug's breast cancer indication, saying Avastin had not been proven to be safe or effective for that ... www.rxlist.com/script/main/art.asp?articlekey=125395 |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment